Literature DB >> 9018644

AGUS in cervical endometriosis.

D A Symonds1, T P Reed, S M Didolkar, R R Graham.   

Abstract

OBJECTIVE: To evaluate cervical endometriosis as a source of abnormal glandular cells in cervicovaginal smears. STUDY
DESIGN: Histologically documented cases of cervical endometriosis with concurrent cervicovaginal smears were reviewed. The cytologic specimens were evaluated for the presence of glandular abnormalities.
RESULTS: There were eight cases of superficial endometriosis (five of which had concurrent tuboendometrioid glandular metaplasia) and two cases of deep endometriosis in this series. Five of the eight cases of superficial endometriosis had abnormal glandular cells in the smears; neither of two cases of deep endometriosis had glandular abnormalities. Four of the eight cases of superficial endometriosis had previously undergone conization for cervical intraepithelial neoplasia (CIN) (squamous intraepithelial lesion [SIL]) and were being monitored for recurrence. Of the five cases of atypical glandular cells of unknown significance (AGUS), one case had concurrent high grade CIN (SIL). Another case was originally misinterpreted as recurrent glandular dysplasia.
CONCLUSION: Physicians monitoring patients after treatment for CIN need to be aware that endometriosis and tuboendometrioid metaplasia may be the source of atypical glandular cells and on occasion may be subject to misinterpretation.

Entities:  

Mesh:

Year:  1997        PMID: 9018644

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

1.  Cervical endometriosis, a case presenting with intractable spotting.

Authors:  Baris Ata; Ugur Ates; Taner Usta; Erkut Attar
Journal:  MedGenMed       Date:  2005-04-07

2.  Endometriosis mimicking glandular atypia in a cervical cytology.

Authors:  Paula A Rodriguez-Urrego; Isabel C Dulcey-Hormiga; Luis E Barrera-Herrera; David A Suarez-Zamora; Mauricio A Palau-Lazaro; Catalina Buritica-Cifuentes
Journal:  J Cytol       Date:  2017 Jan-Mar       Impact factor: 1.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.